UA111364C2 - Фармацевтична композиція для лікування фізичної залежності в людини - Google Patents
Фармацевтична композиція для лікування фізичної залежності в людиниInfo
- Publication number
- UA111364C2 UA111364C2 UAA201400601A UAA201400601A UA111364C2 UA 111364 C2 UA111364 C2 UA 111364C2 UA A201400601 A UAA201400601 A UA A201400601A UA A201400601 A UAA201400601 A UA A201400601A UA 111364 C2 UA111364 C2 UA 111364C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- human beings
- dependency
- treating
- treating dependency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід стосується фармацевтичної композиції для лікування фізичної залежності людей, що складається з двох активних інгредієнтів:- сполуки, що має антагоністичну активність щодо 5-НТ2 рецепторів серотоніну, яка вибрана з ципрогептадину і- сполуки, що має антагоністичну активність щодо альфа-1-норадренергічних рецепторів, вибрана з групи, що складається з празозину, альфузозину, теразозину, тамсулозину, силодозину і доксазозину. Винахід також стосується фармацевтичного продукту.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1155631A FR2976807B1 (fr) | 2011-06-24 | 2011-06-24 | Composition pharmaceutique pour le traitement de la dependance chez l'etre humain |
PCT/FR2012/051443 WO2012175894A1 (fr) | 2011-06-24 | 2012-06-25 | Composition pharmaceutique pour le traitement de la dependance chez l'etre humain |
Publications (1)
Publication Number | Publication Date |
---|---|
UA111364C2 true UA111364C2 (uk) | 2016-04-25 |
Family
ID=46579182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201400601A UA111364C2 (uk) | 2011-06-24 | 2012-06-25 | Фармацевтична композиція для лікування фізичної залежності в людини |
Country Status (4)
Country | Link |
---|---|
FR (1) | FR2976807B1 (uk) |
RU (1) | RU2605283C2 (uk) |
UA (1) | UA111364C2 (uk) |
WO (1) | WO2012175894A1 (uk) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3017296A1 (fr) * | 2013-11-28 | 2015-08-14 | Greenpharma Sas | Composition pharmaceutique pour le traitement de la dependance chez l'etre humain |
FR3138303A1 (fr) * | 2022-07-26 | 2024-02-02 | Kinnov Therapeutics | Composition pharmaceutique pour le traitement du syndrome de stress post-traumatique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2190392C1 (ru) * | 2001-09-14 | 2002-10-10 | Нестерук Владимир Викторович | Фармацевтическая композиция на основе доксазозина |
FR2873294B1 (fr) | 2004-07-26 | 2008-05-09 | Greenpharma Sa Sa | Association de medicaments |
WO2006017861A2 (en) * | 2004-08-13 | 2006-02-16 | Omeros Corporation | Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists |
FR2954699B1 (fr) * | 2009-12-30 | 2012-01-20 | Greenpharma Sas | Composition pharmaceutique pour le traitement de la dependance a l'alcool |
-
2011
- 2011-06-24 FR FR1155631A patent/FR2976807B1/fr active Active
-
2012
- 2012-06-25 WO PCT/FR2012/051443 patent/WO2012175894A1/fr active Application Filing
- 2012-06-25 RU RU2014101958/15A patent/RU2605283C2/ru active
- 2012-06-25 UA UAA201400601A patent/UA111364C2/uk unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012175894A1 (fr) | 2012-12-27 |
FR2976807B1 (fr) | 2013-07-05 |
RU2605283C2 (ru) | 2016-12-20 |
RU2014101958A (ru) | 2015-07-27 |
FR2976807A1 (fr) | 2012-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
CY1124311T1 (el) | Παρεμποδιστες dna-pk | |
EA201400772A1 (ru) | Варианты полипептидов ph20, композиции на их основе и их применение | |
SA518391170B1 (ar) | مركبات باي أريل مفيدة لعلاج الأمراض البشرية في علم الأمراض، طب الأعصاب وعلم المناعة | |
EA201390060A1 (ru) | Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
EA201590987A1 (ru) | Соединения и способы их применения | |
EA201491339A1 (ru) | Замещенные аннеллированные пиримидины и триазины и их применение | |
EA201391416A1 (ru) | Новые соединения в качестве модуляторов протеинкиназ | |
EA201290836A1 (ru) | Связанные бис-арильные арилтриазолоны и их применение | |
EA201300987A1 (ru) | Фармацевтические композиции, включающие метформин и ингибитор dpp-4 или ингибитор sglt-2 | |
MX343687B (es) | Compuestos sulfonamida tricíclica y métodos para su fabricación y uso. | |
EA201391644A1 (ru) | Частично насыщенные трициклические соединения и способы их получения и применения | |
EA201490423A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА | |
EA202090183A1 (ru) | Композиции, способы и получение дейтерированного домперидона | |
EA201492040A1 (ru) | Бициклически замещённые урацилы и их применение | |
EA201490037A1 (ru) | Антагонисты trpv4 | |
MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
EA201400623A1 (ru) | Новые 2h-индазолы в качестве антагонистов рецептора ep | |
CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
EA201791009A1 (ru) | Композиции, содержащие циклоспорин | |
EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
EA201792445A1 (ru) | Новые амидогетероарилароилгидразидэтины |